- Home
- ARCT vs ATRO Comparison
ARCT vs ATRO Comparison
Compare ARCT & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- ATRO
- Stock Information
- Founded
- ARCT 2013
- ATRO 1968
- Country
- ARCT United States
- ATRO United States
- Employees
- ARCT N/A
- ATRO N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- ARCT Health Care
- ATRO Industrials
- Exchange
- ARCT Nasdaq
- ATRO Nasdaq
- Market Cap
- ARCT 487.0M
- ATRO 592.4M
- IPO Year
- ARCT N/A
- ATRO N/A
- Fundamental
- Price
- ARCT $16.79
- ATRO $16.91
- Analyst Decision
- ARCT Strong Buy
- ATRO Hold
- Analyst Count
- ARCT 7
- ATRO 1
- Target Price
- ARCT $65.00
- ATRO $17.00
- AVG Volume (30 Days)
- ARCT 400.9K
- ATRO 282.9K
- Earning Date
- ARCT 03-06-2025
- ATRO 02-26-2025
- Dividend Yield
- ARCT N/A
- ATRO N/A
- EPS Growth
- ARCT N/A
- ATRO N/A
- EPS
- ARCT N/A
- ATRO N/A
- Revenue
- ARCT $160,399,000.00
- ATRO $782,178,000.00
- Revenue This Year
- ARCT $7.33
- ATRO $15.70
- Revenue Next Year
- ARCT $4.71
- ATRO $6.98
- P/E Ratio
- ARCT N/A
- ATRO N/A
- Revenue Growth
- ARCT N/A
- ATRO 19.95
- 52 Week Low
- ARCT $14.30
- ATRO $14.13
- 52 Week High
- ARCT $45.00
- ATRO $23.74
- Technical
- Relative Strength Index (RSI)
- ARCT 46.15
- ATRO 58.88
- Support Level
- ARCT $16.07
- ATRO $15.56
- Resistance Level
- ARCT $17.95
- ATRO $17.10
- Average True Range (ATR)
- ARCT 1.36
- ATRO 0.55
- MACD
- ARCT -0.07
- ATRO 0.17
- Stochastic Oscillator
- ARCT 14.86
- ATRO 88.62
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.